DR. JOHN WAPLES M.D. NPI 1790765337

NPI Details

DR. John Waples, M.D. is a medical oncology internal medicine in Huntsville, AL with 34 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. John Waples, M.D. NPI is 1790765337. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:1992

The provider's business location address is:

3601 CCI DR NW
HUNTSVILLE, AL
ZIP 35805-606
Phone: (256) 705-4224
Fax: (256) 705-4135

The NPI 1790765337 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, levoleucovorin (khapzory), 0.5 mg (HCPCS:J0642)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, lanreotide, 1 mg (HCPCS:J1930)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Magnesium level (HCPCS:83735)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Iron level (HCPCS:83540)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Phosphate level (HCPCS:84100)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Nephelometry, test method using light (HCPCS:83883)
• Folic acid level, serum (HCPCS:82746)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Protein measurement, serum (HCPCS:84165)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Automated urinalysis test (HCPCS:81003)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Urine volume measurement (HCPCS:81050)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Total protein level, urine (HCPCS:84156)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Protein measurement, body fluid (HCPCS:84166)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, clotting time (HCPCS:85610)
• Drawing of blood for a medical problem (HCPCS:99195)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Blood creatinine level (HCPCS:82565)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Erythropoietin (protein) level (HCPCS:82668)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Immunologic analysis technique on body fluid, other fluids with concentration (HCPCS:86335)
• Uric acid level, blood (HCPCS:84550)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Administration of vaccine (HCPCS:90471)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Cholesterol level (HCPCS:82465)

The enumeration date for this NPI number is 1/19/2006 and was last updated on 9/29/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.